Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma

Journal of Pathology

Volumn 195, Issue 3, 2001, Pages 343-348

  Bei, Roberto ^a,b   Pompa, Giorgio ^c   Vitolo, Domenico ^a   Moriconi, Enrica ^a   Ciocci, Luciano ^a   Quaranta, Manlio ^c   Frati, Luigi ^a,d   Kraus, Matthias H ^e   Muraro, Raffaella ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d IRCCS NEUROMED   (Italy)

^e University of Alabama at Birmingham   (United States)

Author keywords

Co expression; EGFR; ErbB3; ErbB4; Oral activity; Receptors; Squamous cell carcinoma

Indexed keywords

DIMER; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; POLYCLONAL ANTIBODY;

ARTICLE; BENIGN TUMOR; CANCER CLASSIFICATION; CANCER INVASION; CARCINOMA IN SITU; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; EPITHELIUM CELL; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUTH CARCINOMA; MOUTH MUCOSA; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3;

EID: 0034782219     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.965     Document Type: Article

References (27)

1. Receptor protein-tyrosine kinases and their signal transduction pathways
2. A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signalling
3. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signalling
4. The ErbB signalling network: Receptor heterodimerization in development and cancer
5. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas
6. Oncogenes in head and neck cancer
7. Prognostic implications of epidermal growth receptor immunoreactivity in squamous cell carcinoma of the oral mucosa
8. Evaluation of epidermal growth factor receptor in squamous cell carcinoma of the oral cavity
9. Expression of epidermal growth factor receptor on oral squamous cell carcinoma
10. Prognostic significance of ERBB3 overexpression in oral squamous cell carcinoma
11. The erbB oncogenes as prognostic markers in oral squamous cell carcinomas
12. Strong correlation between c-erbB-2 overexpression and overall survival patients with oral squamous cell carcinoma
13. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck
14. Combination of EGFR. Her-2/neu, and Her-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members
15. Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types
16. Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C gamma or GTP-ase-acting protein, distinguishes ErbB-3 signalling from that of other ErbB/EGFR family members
17. Cooperative signaliing of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas
18. Demonstration of ligand-dependent signalling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumour cells
19. Isolation and characterization of ErbB3, a third member of the ErbB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumours
20. Immune responses to all ErbB family receptors detectable in serum of cancer patients
21. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinima cells
22. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor
23. The type 1 growth factor receptor family: New ligands and receptors and their role in breast cancer
24. Expression and function of EGF-related peptides and their receptors in gynecological cancer: From basic science to therapy
25. Synergistic interaction of p185-neu and EGF receptor leads to transformation of rodent fibroblasts
26. Diversification of Neu differentiation factor and epidermal growth factor signalling by combinatorial receptor interactions
27. Transformation of NIH3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2